Stem cell therapy shows promise in toddler with Down syndrome

US wide

A three-year-old baby — born with Down syndrome and having subnormal motor skills — has shown improvement after undergoing stem cell treatment at a hospital [at New Delhi, says doctors.] [While Down syndrome is incurable], stem cell experts have reached a conclusion that stem cell treatment can lead to some improvement giving better life even if no permanent cure can be promised.

Following diagnosis of Down syndrome and subnormal motor skills, the patient was shown to a city-based stem cell expert.

According to the doctor, the patient underwent two sessions of stem cell therapy of which the first session lasted approximately three months.

“By the end of three months, the muscle tone was better in all limbs. He (patient) had started babbling and crawling. He was social and was able to recognize his near ones after the first session,” said Geeta Shroff, stem cell expert with city-based Nutech Mediworld.

According to Shroff, the results and improvements have shown that the new medical technology has the potential to replace damaged neurons, re-establish lost axonal connections, and provide treatment for various neural and congenital disorders.

[Study can be found here.]

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion, and analysis. Read full, original post:ย Baby with down syndrome ‘improves’ after stem cell treatment

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosateโ€”the world's most heavily-used herbicideโ€”pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Mar-27-2026-11_47_30-AM-2
FDAโ€™s expedited drug reviews are hailed in some quarters but other approval practices are problematic
Farmers can talk to plants
Farmers are a major source of misinformationโ€”about farming
Screenshot-2026-05-01-at-1.29.41-PM
Viewpoint: What happens when whole grains meet modern food manufacturing? Labels donโ€™t tell the whole story.
ChatGPT-Image-Apr-13-2026-02_20_22-PM
Viewpoint: Misinformation infodemic? Why assessing evidence is so challengingย 
S
As vaccine rejectionism spreads, measles may be taking a more dangerous turn
Screenshot 2026-05-06 at 2.19
Vaccine shootout at the CDCย 
What explains Homo sapiensโ€™ huge brains? Ancient climate change played a role
Viewpoint: Internal White House documents detail administrationโ€™s strategy to undermine climate science
ChatGPT-Image-May-7-2026-11_28_04-AM-2
โ€˜Conflict entrepreneursโ€™ are driving disinformation and shaping public opinion
Screenshot-2026-04-20-at-2.26.27-PM
Viewpoint โ€” Food-fear world: The latest activist scientists campaign: Cancer-causing additives
ChatGPT-Image-May-6-2026-03_41_05-PM
โ€˜Protecting the integrity of scienceโ€™: Kennedyโ€™s FDA blocks release of taxpayer-funded studies finding COVID and shingles vaccines safe
bigstock opioids on chalkboard with rol
GLP podcast: 'Safe injection sites': enabling drug addiction or saving lives?
Screenshot-2026-05-06-at-2.07.43-PM
Manufacturing a conspiracy: The timeline of howย  the White House embraced the fringe claim that scientists are being mysteriously murdered
circular-bioeconomy-should-focus-on-sustainable-wellbeing
GLP podcast: What's wrong with 'doomsday' environmentalism? It's false.
Screenshot 2026-05-06 at 2.56
Singularity crisis ahead? Can super babies save us from rogue AI geniuses?
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.